Used in pharmaceutical synthesis as a chiral intermediate for developing bioactive molecules, particularly in the production of drugs targeting neurological and psychiatric disorders. Its structure supports the creation of compounds with high enantioselectivity, making it valuable in the development of selective serotonin reuptake inhibitors and related central nervous system agents. Also employed in the preparation of enzyme inhibitors and receptor modulators due to its ability to mimic natural aminoethylbenzimidazole derivatives. Commonly utilized in research settings for asymmetric synthesis and medicinal chemistry optimization.